-
Health-Related Quality of Life of Patients With Epidermolysis Bullosa in Hungary: Results With the EQ-5D-5L and EQ-5D-Y-3L Preference-Based Measurement Tools
Sep 9, 2025, 16:22 PM -
Quantifying the Impact of Data Digital and AI on Health Systems
Sep 9, 2025, 16:22 PM -
Is Greece on Track to Meet the 90% HPV Vaccine Coverage Rate Target by 2030? A Mathematical Modeling Study
Sep 9, 2025, 16:22 PM -
Economic Burden and Health-Related Quality of Life Associated With Schizophrenia in Saudi Arabia
Sep 9, 2025, 16:22 PM -
External Control Arm for PHAROS Trial Patients With Metastatic BRAF V600e Mutated NSCLC Treated With First-Line Encorafenib Plus Binimetinib Using Real-World Data From the French ESME Lung Cancer Database (ERASME STUDY)
Sep 9, 2025, 16:22 PM -
Care Dependency and Sick Leave Patterns in Early Alzheimer's Disease: A Retrospective Claims Data Analysis in Germany
Sep 9, 2025, 16:22 PM -
Enhancing Understanding of Quality of Life in Multiple Sclerosis Through Social Listening: Complementing Traditional HRQoL Measures
Sep 9, 2025, 16:22 PM -
Delayed Impact, Limited Leverage: Revenue Dynamics of Patent-Protected Drugs and the Effectiveness of Price-Volume Agreements in Germany
Sep 9, 2025, 16:22 PM -
Characterizing Comorbidities and Co-Occurring Conditions in Adults with Generalized Anxiety Disorder in the United States
Sep 9, 2025, 16:22 PM -
Feasibility of Building a Generic Partitioned Survival Model for Oncology: Essential Components and Technical Implementation
Sep 9, 2025, 16:22 PM -
Patient Pathways to Accessing Unregistered Medicines in Low-Priority Launch Markets
Sep 9, 2025, 16:22 PM -
Hidden Obesity and Treatment Gaps in Japan: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM -
Prediction of Query Outcomes in the Setting of Observational Studies
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of High-Energy High-Protein (HEHP) Oral Nutritional Support (ONS) for the Treatment of Disease-Related Malnutrition (DRM) in Cancer Patients in the French Community Setting
Sep 9, 2025, 16:22 PM -
Germany: Still a Benchmark for ATMP Access and Pricing: A Pricing Analysis of Germany's ATMP Landscape Compared to Other European Countries
Sep 9, 2025, 16:22 PM -
An Economic Evaluation of Risankizumab vs. Adalimumab in Moderate to Severe Plaque Psoriasis Adult Patients in Egypt
Sep 9, 2025, 16:22 PM -
Ensuring Patient Inclusion When Baseline Is Missing: Utilizing Constrained Longitudinal Data Analysis (cLDA) for Patient-Reported Outcomes (PROs)
Sep 9, 2025, 16:22 PM -
Societal and Economic Impact of Immunotherapy for NSCLC Treatment in Bulgaria
Sep 9, 2025, 16:22 PM -
Estimation of HER2-Negative Metastatic Breast Cancer Population Eligible for Innovative Treatments in France
Sep 9, 2025, 16:22 PM -
Designing an Adaptive Governance Framework for Strategic Alignment Between Health Insurers and Providers in Complex Health Systems: A Case Study From the Colombian Caribbean
Sep 9, 2025, 16:22 PM